Class A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
Subclass 1/16: Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 11998541 | Method for alleviating chronic liver disease using Rosoxacin | Nov 11, 22 | Jun 04, 24 | NATIONAL YANG MING CHIAO TUNG UNIVERSITY |
| 11999718 | Pyrazole derivatives | Jan 06, 23 | Jun 04, 24 | APTABIO THERAPEUTICS INC. |
| 11999722 | Disubstituted pyrazole compounds | Sep 17, 21 | Jun 04, 24 | Applied Molecular Evolution Inc. c/o Eli Lilly and Company Patent Division |
| 11992499 | Quinoline derivatives for use in the treatment of inflammation diseases | Dec 19, 19 | May 28, 24 | ABIVAX; (1) Imstar Image et Modelisation: Strategie Analyse et Realisation (2) Institut Curie (et al); UNIVERSITE DE MONTIPELLIER; Centre National De La Recherche Scientifique (CNRS); |
| 11986501 | Treatment methods and compositions | Jul 16, 19 | May 21, 24 | UNM Rainforest Innovations |
| 11987791 | Compositions and methods for modulating hepatocyte nuclear factor 4-alpha (HNF4α) gene expression | Sep 23, 20 | May 21, 24 | Omega Therapeutics, Inc. |
| 11980672 | Heterologous UTR sequences for enhanced mRNA expression | Jun 21, 22 | May 14, 24 | ModernaTX, Inc. |
| 11975046 | Medical use of interferon-lambda for the treatment of fibrosis | Jun 29, 23 | May 07, 24 | UCB Biopharma SRL; Five Prime Therapeutics, Inc.; |
| 11976096 | Antibody-evading virus vectors | Sep 26, 23 | May 07, 24 | Ginkgo BioWorks, Inc. |
| 11970484 | LXR modulators with bicyclic core moiety | Feb 09, 23 | Apr 30, 24 | OrsoBio, Inc. |
| 11970523 | Long-acting oxyntomodulin hybrid peptide, preparation method therefor, and application thereof | May 06, 19 | Apr 30, 24 | China Pharmaceutical University |
| 11963961 | Combination therapy comprising an ACC inhibitor | Mar 17, 21 | Apr 23, 24 | Gilead Sciences, Inc. |
| 11963989 | Application of medical cell CMU-pb-7 in preparation of blood lipid-lowering drugs | Jun 17, 23 | Apr 23, 24 | GUANGDONG XINGHAI BIOTECHNOLOGY CO., LTD.; GUANGDONG XINGHAI INSTITUTE OF CELL; |
| 11964960 | Pyridinone- and pyridazinone-based compounds and uses thereof | Mar 08, 19 | Apr 23, 24 | Cornell University; Tri-Institutional Therapeutics Discovery Institute; |
| 11965034 | Antifibrotic activity of CD47 blockade in the liver | Feb 09, 22 | Apr 23, 24 | The Board of Trustees of the Leland Stanford Junior University |
| 11957687 | Modulators of HSD17B13 and methods of use thereof | Jul 01, 20 | Apr 16, 24 | Regeneron Pharmaceuticals, Inc. |
| 11957704 | Methods of treating metabolic disorders and cardiovascular disease with inhibin subunit beta E (INHBE) inhibitors | Aug 31, 22 | Apr 16, 24 | Regeneron Pharmaceuticals, Inc. |
| 11938122 | 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3- thiazolidine-2,4-dione for treating nonalcoholic fatty liver disease | Dec 01, 17 | Mar 26, 24 | Minoryx Therapeutics S.L. |
| 11938172 | Method for regulating and controlling GLP-1/GLP-1R and drug | Jun 19, 18 | Mar 26, 24 | TALENGEN INTERNATIONAL LIMITED |
| 11939343 | Sting agonist compounds and methods of use | Sep 09, 21 | Mar 26, 24 | MERSANA THERAPEUTICS, INC. |
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2024/0180,898 | USE OF AMINOTHIAZOLE DERIVATIVE IN TREATMENT OF IMMUNE INFLAMMATION | Feb 02, 24 | Jun 06, 24 | Not available |
| 2024/0180,985 | FOOD AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF FATTY LIVER AND INFLAMMATION BY RELIEVING ENDOPLASMIC RETICULUM STRESS | Nov 27, 23 | Jun 06, 24 | PICOENTECH Co., LTD. |
| 2024/0182,862 | METHOD FOR PRODUCING MESENCHYMAL STEM CELLS | Dec 08, 23 | Jun 06, 24 | AJINOMOTO CO., INC. |
| 2024/0173,288 | COMPOUNDS, COMPOSITIONS, METHODS OF USING, AND METHODS FOR PREPARING COMPOUNDS | Oct 26, 23 | May 30, 24 | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.; THE INSTITUTE FOR STEM CELL BIOLOGY AND REGENERATIVE MEDICINE (INSTEM); |
| 2024/0173,317 | METHODS FOR TREATING PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS | Oct 23, 23 | May 30, 24 | Mirum Pharmaceuticals, Inc. |
| 2024/0173,333 | Treating Alagille Syndrome (ALGS) | Nov 03, 23 | May 30, 24 | Not available |
| 2024/0173,367 | COMPOSITIONS AND METHODS FOR TREATING CHOLESTATIC DISEASE | May 17, 23 | May 30, 24 | Seres Therapeutics, Inc. |
| 2024/0174,688 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY | Oct 05, 23 | May 30, 24 | Not available |
| 2024/0165,202 | USES OF FGF21 POLYPEPTIDES AND FUSION POLYPEPTIDES THEREOF | Mar 18, 22 | May 23, 24 | Sunshine Lake Pharma Co., Ltd. |
| 2024/0165,206 | USE OF ALBUMIN FOR THE TREATMENT OF DEFECTIVE B-CELL FUNCTION | Mar 25, 22 | May 23, 24 | Not available |
| 2024/0165,119 | METHODS OF TREATING LIVER DISEASE | Oct 26, 23 | May 23, 24 | Not available |
| 2024/0165,193 | Treatment of Ascites | Jan 23, 24 | May 23, 24 | Not available |
| 2024/0166,746 | DOSAGE REGIMEN OF MAdCAM-1 ANTIBODY FOR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS | Nov 21, 23 | May 23, 24 | Not available |
| 2024/0156,760 | SUBSTITUTED FATTY ACIDS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | Jan 17, 24 | May 16, 24 | Not available |
| 2024/0156,769 | FATTY ACID DERIVATIVES FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | Jan 22, 24 | May 16, 24 | Not available |
| 2024/0156,778 | THIOPHENE DERIVATIVES FOR USE IN TREATING PORTAL INFLAMMATION AND FIBROSIS | Oct 16, 20 | May 16, 24 | Not available |
| 2024/0156,825 | USE OF SELECTIVE VEGFR2 AND FGFR1 INHIBITORS | Jun 09, 23 | May 16, 24 | Not available |
| 2024/0156,826 | METHODS OF TREATING LIVER DISORDERS OR LIPID DISORDERS WITH A THR-BETA AGONIST | Sep 21, 23 | May 16, 24 | Not available |
| 2024/0156,880 | BACTERIOTHERAPY | Aug 09, 23 | May 16, 24 | Not available |
| 2024/0156,987 | NUCLEIC ACID PRODUCTS AND METHODS OF ADMINISTRATION THEREOF | Jun 02, 23 | May 16, 24 | Not available |
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
